1 Einträge von mit plasma trial
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:32:23
erkannte Namen Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
Kombination Keywords behring search | your find | bern hereditary | careers policy | switzerland patients | disease phase | more learn | news global | company rare | plasma products |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
plasma. Learn More R&D Switzerland at a glance: We are strengthening our local R&D network to contribute to our global strategic goals. Read About R&D Patients Patients Community Engagement Find Your Disease Find Your Disease Immunodeficiency and Aut trial? A potential hyperimmune treatment for COVID-19 reaches a regulatory milestone in testing its efficacy and safety. 06 Nov 2020 First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine As co-leader, CSL Behr
Text Inhalt Text aus URL
Log Metriken 86122
erkannte Namen Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
Kombination Keywords behring search | your find | bern hereditary | careers policy | switzerland patients | disease phase | more learn | news global | company rare | plasma products |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
plasma. Learn More R&D Switzerland at a glance: We are strengthening our local R&D network to contribute to our global strategic goals. Read About R&D Patients Patients Community Engagement Find Your Disease Find Your Disease Immunodeficiency and Aut trial? A potential hyperimmune treatment for COVID-19 reaches a regulatory milestone in testing its efficacy and safety. 06 Nov 2020 First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine As co-leader, CSL Behr
Text Inhalt Text aus URL
Log Metriken 86122
URL /en-us/news/2020